6725-3430 Screening compound: N-(2-methyl-5-{6-methyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl}phenyl)-2-(morpholin-4-yl)acetamide

6725-3430 Screening compound: N-(2-methyl-5-{6-methyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl}phenyl)-2-(morpholin-4-yl)acetamide
6725-3430 Screening compound: N-(2-methyl-5-{6-methyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl}phenyl)-2-(morpholin-4-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 6725-3430
N-(2-methyl-5-{6-methyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl}phenyl)-2-(morpholin-4-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6725-3430

Molecular Formula

C23H24N6O2 (C23 H24 N6 O2)

Compound Name

N-(2-methyl-5-{6-methyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl}phenyl)-2-(morpholin-4-yl)acetamide

IUPAC name

N-(2-methyl-5-{6-methyl-[124]triazolo[34-a]phthalazin-3-yl}phenyl)-2-(morpholin-4-yl)acetamide

SMILES

Cc(ccc(-c1nnc2n1nc(C)c1c2cccc1)c1)c1NC(CN1CCOCC1)=O

InChI

InChI=1S/C23H24N6O2/c1-15-7-8-17(13-20(15)24-21(30)14-28-9-11-31-12-10-28)22-25-26-23-19-6-4-3-5-18(19)16(2)27-29(22)23/h3-8,13H,9-12,14H2,1-2H3,(H,24,30)

InChI Key

CHYCFRZVTJOEHL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04026628

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

416.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.634

Distribution Coefficient, logD

2.633

Water Solubility, LogSw

-2.99

Polar Surface Area

67.341

Acid Dissociation Constant (pKa)

12.66

Base Dissociation Constant (pKb)

4.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

6725-3430 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with 6725-3430 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6725-3430?
Check Price and Availability of 6725-3430, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6725-3430 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6725-3430
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6725-3430
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6725-3430 available by request